Literature DB >> 21755519

Outcome of pregnancies complicated by oligohydramnios or anhydramnios of renal origin.

E W M Grijseels1, P T M Echteld van-Hornstra, L C P Govaerts, T E Cohen-Overbeek, R R de Krijger, B J Smit, K Cransberg.   

Abstract

OBJECTIVE: To evaluate the outcome of fetuses with oligohydramnios due to kidney anomalies.
METHODS: A retrospective study was performed of all pregnancies diagnosed with oligohydramnios and associated kidney anomalies during the period 2000-2008. Outcome included pregnancy outcome, mortality, and morbidity. Morbidity included renal function based on the glomerular filtration rate (GFR) during follow-up.
RESULTS: A total of 71 pregnancies were evaluated; 36 fetuses presented on ultrasound with cystic dysplasia, 15 with polycystic kidney disease (PKD) and 20 with hydronephrosis. Twenty-three (32%) had associated anomalies. In 49 fetuses (69%), the diagnosis had been made before 24 weeks of gestational age (GA); 41 of those pregnancies were terminated. Twenty-five neonates were live born: 10 survived, 15 died. Prognostic factors for survival included GA at diagnosis (32.2 weeks for survivors vs 28.1 weeks for non-survivors; P = 0.02), diagnosis of hydronephrosis (7 in the survivors vs 4 in the non-survivors: P = 0.05), isolated anomaly (9 in the survivors vs 7 in the non-survivors: P = 0.04). Severity of oligohydramnios (1 case of anhydramnios in the survivors vs 7 in the non-survivors: P = 0.08) was not significant. The 1-year GFR was below 50 mL/min.1.73 m(2) in four of the ten survivors.
CONCLUSION: The prognosis of early onset renal oligohydramnios is poor. Predictive determinants of survival are: GA at diagnosis, nature of renal anomaly (hydronephrosis vs other), and presence of associated anomalies.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21755519     DOI: 10.1002/pd.2827

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Causes of renal oligohydramnios: impact on prenatal counseling and postnatal outcome.

Authors:  Sebastian Loos; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2017-11-11       Impact factor: 3.714

Review 2.  Evidence-based, ethically justified counseling for fetal bilateral renal agenesis.

Authors:  Alana N Thomas; Laurence B McCullough; Frank A Chervenak; Frank X Placencia
Journal:  J Perinat Med       Date:  2017-07-26       Impact factor: 1.901

Review 3.  Severe antenatally diagnosed renal disorders: background, prognosis and practical approach.

Authors:  Wiebke Aulbert; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2015-06-17       Impact factor: 3.714

Review 4.  Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group.

Authors:  Valentina Capone; Nicola Persico; Alfredo Berrettini; Stèphane Decramer; Erika Adalgisa De Marco; Diego De Palma; Alessandra Familiari; Wout Feitz; Maria Herthelius; Vytis Kazlauskas; Max Liebau; Gianantonio Manzoni; Michal Maternik; Giovanni Mosiello; Joost Peter Schanstra; Johan Vande Walle; Elke Wühl; Elisa Ylinen; Aleksandra Zurowska; Franz Schaefer; Giovanni Montini
Journal:  Nat Rev Urol       Date:  2022-02-08       Impact factor: 16.430

5.  Severe congenital anomalies of the kidney and urinary tract: epidemiology can inform ethical decision-making.

Authors:  P Danziger; D R Berman; K Luckritz; K Arbour; N Laventhal
Journal:  J Perinatol       Date:  2016-07-28       Impact factor: 2.521

6.  Prenatal parental decision-making and postnatal outcome in renal oligohydramnios.

Authors:  Katrin Mehler; Ingo Gottschalk; Kathrin Burgmaier; Ruth Volland; Anja K Büscher; Markus Feldkötter; Titus Keller; Lutz T Weber; Angela Kribs; Sandra Habbig
Journal:  Pediatr Nephrol       Date:  2017-10-27       Impact factor: 3.714

7.  Two novel deleterious variants of Angiotensin-I-converting Enzyme gene identified in a family with recurrent anhydramnios.

Authors:  Jingwei Wang; Qiao Bin; Biheng Cheng; Li Yan; Liang Xiong; Bi-Hua Tan; Mary McGrath; Gayle M Smink; Chunhua Song; Yongqing Tong
Journal:  Mol Genet Genomic Med       Date:  2020-04-23       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.